Guidance for Industry: FDA's Policy on Declaring Small Amounts of Nutrients and Dietary Ingredients on Nutrition Labels


How to Comment

The comment period opens July 5, 2016.

Submit electronic comments on to docket number FDA-2015-D-1839.

Submit written comments to:

Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, rm. 1061
Rockville, MD 20852
All comments should be identified with the docket number FDA-2015-D-1839.

Contains Nonbinding Recommendations

July 2016  

This guidance addresses how conventional food and dietary supplement manufacturers should declare small amounts of nutrients and dietary ingredients on nutrition labels. 

It specifically explains how FDA intends to consider exercising enforcement discretion when a conflict occurs between compliance with Title 21 of the Code of Federal Regulations (21 CFR), section 101.9(c), and compliance with 21 CFR 101.9(g) such that compliance with both sections is not possible

FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe our current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.  The use of the word should in FDA guidances means that something is suggested or recommended, but not required. 

Download Guidance for Industry
(PDF 80KB)

Page Last Updated: 09/16/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English